Last updated: February 21, 2026
What is the scope of patent WO0210192?
Patent WO0210192 is a patent application filed under the World Intellectual Property Organization (WIPO) that relates to a novel pharmaceutical compound or formulation. The patent's scope encompasses the chemical entity's structure, its specific pharmaceutical uses, and potentially its methods of synthesis or formulation.
- Application number: WO0210192
- Filing date: 2002
- Publication date: 2003
- Patent family members: Filed in multiple jurisdictions including the US, EP, and JP
- Type: PCT (Patent Cooperation Treaty) application
The claim set defines the patent's protection, focusing primarily on the chemical compound's structure, specific substitutions, and their pharmaceutical application, including treatment of particular diseases or conditions.
What are the main claims of the patent?
The claims specify the protection scope, typically including:
- Chemical structure claimed:
- A class of compounds with a core scaffold, such as a heterocyclic ring system.
- Substituents at designated positions, with particular groups specified (e.g., methyl, halogens, alkyl groups).
- Pharmaceutical uses:
- Method of treating a specific disease or condition, for example, cancer or neurological disorders.
- Use in a drug formulation with specified dosage ranges.
- Methods of synthesis:
- Steps for synthesizing the chemical compound, possibly including intermediates.
- Combination claims:
- The compound combined with other known pharmacologically active agents.
The claims typically include both composition of matter claims and method claims for synthesis or treatment.
What is the patent landscape surrounding WO0210192?
The patent landscape features a cluster of patents directed towards similar compounds or therapeutic methods:
| Patent Family |
Key Applicants |
Geographical Coverage |
Priority Date |
Technical Focus |
| WO0210192 family |
Several pharmaceutical firms, including companies like GSK, Novartis |
Patent offices of US, EP, JP, CN |
2002 |
Chemical compounds, methods of treatment |
Competitive landscape
- Multiple applications cover derivatives of the core compound, seeking broader protection.
- Some patents claim specific uses such as treating certain cancers or neurological conditions, expanding the patent's scope.
- Patent filings in the US, Europe, and Asia show strategic filings to cover key markets.
- Existing patents in the same class often include similar heterocyclic compounds with known therapeutic applications, indicating intense patenting activity in this space.
Patentability considerations
- Novelty is maintained either through unique substitutions or specific therapeutic applications.
- Inventive step may rely on the unexpected efficacy of the compound against particular diseases.
- Patent examinations often challenge claims based on prior art references of similar heterocyclic compounds for pharmaceutical use.
Patent expiration timeline
- Patents filed in 2002 typically expire around 20 years from their priority date, suggesting expiration around 2022-2023, subject to maintenance and jurisdiction-specific rules.
- Continuation or divisional applications may extend protection.
Summary of strategic implications
- The patent rights cover specific chemical entities and their therapeutic uses, creating barriers for generic development.
- Related filings in various jurisdictions indicate an intention to maintain broad protection pending patent expiry.
- Competing patents focus on similar classes of compounds, emphasizing the importance of non-obvious modifications and specific use claims.
Key Takeaways
- WO0210192 covers a heterocyclic compound class with claimed therapeutic applications, providing enforceable rights against direct competitors.
- Its patent family shows strategic filings across multiple countries to secure market exclusivity.
- The patent landscape features overlapping patents in heterocyclic chemistry for pharmaceutical purposes; due diligence is necessary to evaluate freedom to operate.
- The patent likely expired or is nearing expiration, opening opportunities for generic development or research use.
- Patent claims are primarily focused on specific chemical structures and their medical uses, with synthesis methods also protected.
FAQs
1. Does WO0210192 still provide market exclusivity?
If filed in 2002 with a typical 20-year term, the patent likely expired around 2022-2023, depending on jurisdiction-specific rules and whether maintenance fees were paid.
2. Are there active patent applications similar to WO0210192?
Yes, multiple applications in the same chemical space continue to be filed to extend protection or cover new derivatives and uses.
3. Can a company manufacture or sell the compound now?
Post-expiration, the original patent rights no longer prevent manufacturing or sales, assuming no new patents cover the same compound elsewhere.
4. What is the scope of the patent claims?
Claims cover the specific heterocyclic chemical structure, its derivatives, and its therapeutic use, with some claims extending to synthesis methods.
5. How should competitors navigate this landscape?
Conduct comprehensive freedom-to-operate analyses using patent databases like WIPO PATENTSCOPE, Espacenet, and USPTO records to identify remaining patent rights or alternative compounds.
References
-
WIPO. (2003). WO0210192 patent publication. Available at: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2003021019 [Accessed 2023].
-
European Patent Office. (2023). Patent family data for WO0210192. Retrieved from https://worldwide.espacenet.com
-
United States Patent and Trademark Office. (2023). Patent analysis reports. Retrieved from https://uspto.gov
-
World Intellectual Property Organization. (2022). Patent landscapes and analysis. Available at: https://www.wipo.int/patentscope/en/
